Lipofilling after Laser-Assisted Treatment for Facial Filler Complication: Volumetric and Regenerative Effect.
Adult
Cicatrix
/ etiology
Dermal Fillers
/ adverse effects
Esthetics
Face
/ surgery
Facial Asymmetry
/ etiology
Female
Follow-Up Studies
Foreign-Body Reaction
/ etiology
Humans
Lasers, Semiconductor
/ therapeutic use
Male
Middle Aged
Patient Satisfaction
/ statistics & numerical data
Subcutaneous Fat
/ transplantation
Treatment Outcome
Journal
Plastic and reconstructive surgery
ISSN: 1529-4242
Titre abrégé: Plast Reconstr Surg
Pays: United States
ID NLM: 1306050
Informations de publication
Date de publication:
01 03 2021
01 03 2021
Historique:
entrez:
23
2
2021
pubmed:
24
2
2021
medline:
3
8
2021
Statut:
ppublish
Résumé
Nonresorbable substances are still injected to enhance soft-tissue volumes and fill subcutaneous defects. The minimally invasive intralesional laser treatment can remove foreign substances and the inflammatory reaction, eventually leaving depression and scar tissue in the treated area. Fat grafting can restore volume loss and improve scar tissue. From March of 2010 to February of 2017, 33 patients were studied. All of them had suffered from inflammatory reactions to permanent facial fillers and had been treated with the 808-nm diode laser at the authors' institution. The evacuation of material had left facial asymmetry and visible depression. To restore facial aesthetic units, fat grafting was performed. The minimum follow-up was 6 months. Volume restoration was recognized (according to the Global Aesthetic Improvement Scale) as significantly improved in 22 patients, moderately improved in eight patients, and slightly improved in three patients. Improvement in atrophic and scarred tissues (with an apparent thickening of the skin or even elimination of scars) was also assessed with the following results: 25 patients were very much improved and eight were moderately improved. This is the first study on filler-induced complications of the face treated by intralesional laser treatment followed by lipofilling. A systematic approach to volume restoration is proposed to patients who had filler removal of the face. There was a high degree of patient satisfaction with this technique. Therapeutic, IV.
Sections du résumé
BACKGROUND
Nonresorbable substances are still injected to enhance soft-tissue volumes and fill subcutaneous defects. The minimally invasive intralesional laser treatment can remove foreign substances and the inflammatory reaction, eventually leaving depression and scar tissue in the treated area. Fat grafting can restore volume loss and improve scar tissue.
METHODS
From March of 2010 to February of 2017, 33 patients were studied. All of them had suffered from inflammatory reactions to permanent facial fillers and had been treated with the 808-nm diode laser at the authors' institution. The evacuation of material had left facial asymmetry and visible depression. To restore facial aesthetic units, fat grafting was performed. The minimum follow-up was 6 months.
RESULTS
Volume restoration was recognized (according to the Global Aesthetic Improvement Scale) as significantly improved in 22 patients, moderately improved in eight patients, and slightly improved in three patients. Improvement in atrophic and scarred tissues (with an apparent thickening of the skin or even elimination of scars) was also assessed with the following results: 25 patients were very much improved and eight were moderately improved.
CONCLUSIONS
This is the first study on filler-induced complications of the face treated by intralesional laser treatment followed by lipofilling. A systematic approach to volume restoration is proposed to patients who had filler removal of the face. There was a high degree of patient satisfaction with this technique.
CLINICAL QUESTION/LEVEL OF EVIDENCE
Therapeutic, IV.
Identifiants
pubmed: 33620925
doi: 10.1097/PRS.0000000000007611
pii: 00006534-202103000-00009
doi:
Substances chimiques
Dermal Fillers
0
Types de publication
Journal Article
Video-Audio Media
Langues
eng
Sous-ensembles de citation
IM
Pagination
585-591Commentaires et corrections
Type : CommentIn
Type : CommentIn
Informations de copyright
Copyright © 2021 by the American Society of Plastic Surgeons.
Déclaration de conflit d'intérêts
Disclosure:None of the authors has a financial interest in any of the products or devices mentioned in this article. The authors declare no conflict of interest.
Références
Carruthers JDA, Glogau RG, Blitzer A, et al. Advances in facial rejuvenation: Botulinum toxin type A, hyaluronic acid dermal fillers, and combination therapies. Consensus recommendations. Plast Reconstr Surg. 2008;121(Suppl 5):5S–30S; quiz 31S–36S.
Broder KW, Cohen SR. An overview of permanent and semipermanent fillers. Plast Reconstr Surg. 2006;118(Suppl):7S–14S.
Eppley BL, Dadvand B. Injectable soft-tissue fillers: Clinical overview. Plast Reconstr Surg. 2006;118:98e–106e
Wiest LG. Historie und anwendung der filler zur faltenbehandlung. Hautarzt 2007;58:224–231.
Zielke H, Wölber L, Wiest L, Rzany B. Risk profiles of different injectable fillers: Results from the Injectable Filler Safety Study (IFS Study). Dermatol Surg. 2008;34:326–335; discussion 335.
Rohrich RJ, Monheit G, Nguyen AT, Brown SA, Fagien S. Soft-tissue filler complications: The important role of biofilms. Plast Reconstr Surg. 2010;125:1250–1256.
Requena L, Requena C, Christensen L, Zimmermann US, Kutzner H, Cerroni L. Adverse reactions to injectable soft tissue fillers. J Am Acad Dermatol. 2011;64:1–34.
Nicolau PJ. Long-lasting and permanent fillers: Biomaterial influence over host tissue response. Plast Reconstr Surg. 2007;119:2271–2286.
Christensen L, Breiting V, Janssen M, Vuust J, Hogdall E. Adverse reactions to injectable soft tissue permanent fillers. Aesthetic Plast Surg. 2005;29:34–48.
Rapinini R, Bolognia J, Jorizzo J. Dermatology. 2007.St. Louis: Mosby;
Ratner B, Hoffman A, Schoen F. Biomaterial Science: An Introduction to Materials in Medicine. 2004.2nd ed. Philadelphia: Elsevier Science;
Funt D, Pavicic T. Dermal fillers in aesthetics: An overview of adverse events and treatment approaches. Clin Cosmet Investig Dermatol. 2013;6:295–316.
Sadashivaiah AB, Mysore V. Biofilms: Their role in dermal fillers. J Cutan Aesthet Surg. 2010;3:20–22.
Carruthers A, Carruthers J. (Discussion) Adverse granulomatous reaction to Artecoll treated by intralesional 5-fluorouracil and triamcinolone injections. Dermatol Surg. 2006;32:1082.
Woodward J, Khan T, Martin J. Facial filler complications. Facial Plast Surg Clin North Am. 2015;23:447–458.
Cassuto D, Pignatti M, Pacchioni L, Boscaini G, Spaggiari A, De Santis G. Management of complications caused by permanent fillers in the face: A treatment algorithm. Plast Reconstr Surg. 2016;138:215e–227e.
Coleman SR. Long-term survival of fat transplants: Controlled demonstrations. Aesthetic Plast Surg. 1995;19:421–425.
Coleman SR. Facial recountouring with lipostructure. Clin Plast Surg. 1997;24:347–367.
Narins RS, Brandt F, Leyden J, Lorenc ZP, Rubin M, Smith S. A randomized, double-blind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds. Dermatol Surg. 2003;29:588–595.
Rossner M, Rossner F, Bachmann F, Wiest L, Rzany B. Risk of severe adverse reactions to an injectable filler based on a fixed combination of hydroxyethylmethacrylate and ethylmethacrylate with hyaluronic acid. Dermatol Surg. 2009;35(Suppl 1):367–374.
Bentkover SH. The biology of facial fillers. Facial Plast Surg. 2009;25:73–85.
Christensen L. Normal and pathologic tissue reactions to soft tissue gel fillers. Dermatol Surg. 2007;33:S168–S175.
Christensen LH. Host tissue interaction, fate, and risks of degradable and nondegradable gel fillers. Dermatol Surg. 2009;35:1612–1619.
Laeschke K. Biocompatibility of microparticles into soft tissue fillers. Semin Cutan Med Surg. 2004;23:214–217.
Endara MR, Allred LJ, Han KD, Baker SB. Applications of fat grafting in facial aesthetic skeletal surgery. Aesthetic Surg J. 2014;34:363–373.
Ellenbogen R, Youn A, Yamini D, Svehlak S. The volumetric face lift. Aesthetic Surg J. 2004;24:514–522.
Gamboa GM, Ross WA. Autologous fat transfer in aesthetic facial recontouring. Ann Plast Surg. 2013;70:513–516.
Coleman S, Saboeiro A, Sengelmann R. A comparison of lipoatrophy and aging: Volume deficits in the face. Aesthetic Plast Surg. 2009;33:14–21.
Moratalla Jareño T, González Alonso V, López Blanco E, Domenèch Tárrega A, Carazo Palacios E, Gutiérrez Ontalvillas P. Use of lipofilling in pediatric patients (in Spanish). Cir Pediatr. 2013;26:189–194.
Balaji S. Subdermal fat grafting for Parry-Romberg syndrome. Ann Maxillofac Surg. 2014;4:55–59.
Hunstad JP, Shifrin DA, Kortesis BG. Successful treatment of Parry-Romberg syndrome with autologous fat grafting: 14-year follow-up and review. Ann Plast Surg. 2011;67:423–425.
Salinas HM, Broelsch GF, Fernandes JR, et al. Comparative analysis of processing methods in fat grafting. Plast Reconstr Surg. 2014;134:675–683.
Starnoni M, De Santis G, Pinelli M. Dermal matrix fixation: A good adhesion to wound edges without vascularization impairment. Plast Reconstr Surg Glob Open 2019;7:e2327.
Foppiani EM, Candini O, Mastrolia I, et al. Impact of HOXB7 overexpression on human adipose-derived mesenchymal progenitors. Stem Cell Res Ther. 2019;10:101.